The Prescription Supply Chain Resource Center combines structured and unstructured data to provide real-time insights on the global network the U.S. relies on for prescription drugs. In recent years, the U.S. has experienced shortages in drugs used to treat everything from viral infections to cardiovascular disease.
With increased transparency and actionable, expert policy recommendations, we aim to prevent drug shortages that put American lives at risk.
What causes drug shortages?
Currently, pharmaceutical production is concentrated overseas and we have limited insight into quality safeguards and supply chain gaps that are putting public health on the line.
Can the US rely on domestic production to fill all prescriptions?
Where are drug shortages likely to occur in the future ?
The Pharmaceutical Supply Chain Dashboard uses structured and unstructured data to predict and identify shortages.
What types of drugs are most likely to experience shortages?
Generic drugs are currently most at risk, as they account for 90% of U.S. prescriptions but over two-thirds of shortages.
Funding
This project builds on the Johns Hopkins Prescription Drug Supply Chain Data Dashboard, originally developed with support from a 2024 Johns Hopkins NEXUS Research Award granted to Dr. Mariana Socal. Building on this foundation, the team received a $1.5 million research grant from the U.S. Department of Defense (DoD) to strengthen the resilience of the U.S. pharmaceutical supply chain. This work is part of a broader DOD initiative awarded to the Uniformed Services University’s (USU) Center for Health Services Research